EXAMINATION OF THE DEPHOSPHORYLATION REACTIONS CATALYZED BY PP60(C-SRC) TYROSINE KINASE EXPLORES THE ROLES OF AUTOPHOSPHORYLATION AND SH2 LIGAND-BINDING

被引:8
|
作者
BOERNER, RJ [1 ]
KASSEL, DB [1 ]
EDISON, AM [1 ]
KNIGHT, WB [1 ]
机构
[1] GLAXO INC,RES INST,DIV MOLEC SCI,RES TRIANGLE PK,NC 27709
关键词
D O I
10.1021/bi00045a028
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
pp60(c-src) tyrosine kinase (srcTK) catalyzes the dephosphorylation of phosphotyrosine-containing peptides, including phosphopeptides that bind with high affinity to the src SH2 domain. The mechanism for these dephosphorylation reactions was investigated. Dephosphorylation was inhibited by a competitive inhibitor for the ATP binding site. In the presence of ADP, dephosphorylation of phosphopeptide substrates is primarily due to the reversal of the kinase reaction. Autoactivated and unactivated srcTK both catalyzed the reverse of the kinase reaction; however, autoactivated srcTK displayed an increase in k(cat) of approximately 4-11-fold relative to unactivated srcTK, depending on the reaction conditions. Autoactivation of srcTK does not affect the K-m's for MgADP or phosphopeptide (FGE)(3)-pY-(GEF)(2)GD. Unphosphorylated srcTK becomes phosphorylated during the reverse of the kinase reaction upon accumulation of free MgaTP. In the presence of MgATP, srcTK also dephosphorylates peptide substrates, by first hydrolyzing MgATP to MgADP. Binding of phosphotyrosine peptide ligands to the src SH2 domain stimulated the rate of MgATP hydrolysis approximately 2-fold, but had no effect on the K-m for MgATP. These data suggest that autophosphorylation of tyrosine 419 is not required for nucleotide or peptide binding, or catalysis involving small peptide substrates. In addition, these results suggest that both the forward and the reverse src tyrosine kinase reactions may be important in regulating the intracellular levels of protein tyrosine phosphorylation.
引用
收藏
页码:14852 / 14860
页数:9
相关论文
共 43 条
  • [1] DEPHOSPHORYLATION REACTIONS OF PP60(C-SRC) TYROSINE KINASE
    BOERNER, RJ
    KASSEL, D
    EDISON, A
    KNIGHT, WB
    FASEB JOURNAL, 1995, 9 (06): : A1301 - A1301
  • [2] DIFFERENTIAL BINDING OF PP60(C-SRC) AND PP60(V-SRC) TO CYTOSKELETON IS MEDIATED BY SH2 AND CATALYTIC DOMAINS
    OKAMURA, H
    RESH, MD
    ONCOGENE, 1994, 9 (08) : 2293 - 2303
  • [3] AUTOPHOSPHORYLATION OF THE FOCAL ADHESION KINASE, PP125(FAK), DIRECTS SH2 DEPENDENT BINDING OF PP60(SRC)
    SCHALLER, MD
    HILDEBRAND, JD
    SHANNON, JD
    FOX, JW
    VINES, RR
    PARSONS, JT
    MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (03) : 1680 - 1688
  • [4] SOLUTION STRUCTURE OF THE HUMAN PP60(C-SRC) SH2 DOMAIN COMPLEXED WITH A PHOSPHORYLATED TYROSINE PENTAPEPTIDE
    XU, RX
    WORD, JM
    DAVIS, DG
    RINK, MJ
    WILLARD, DH
    GAMPE, RT
    BIOCHEMISTRY, 1995, 34 (07) : 2107 - 2121
  • [5] Kinetic mechanisms of the forward and reverse pp60(c-src) tyrosine kinase reactions
    Boerner, RJ
    Barker, SC
    Knight, WB
    BIOCHEMISTRY, 1995, 34 (50) : 16419 - 16423
  • [6] Peptide ligands of pp60(c-src) SH2 domains: A thermodynamic and structural study
    Charifson, PS
    Shewchuk, LM
    Rocque, W
    Hummel, CW
    Jordan, SR
    Mohr, C
    Pacofsky, GJ
    Peel, MR
    Rodriguez, M
    Sternbach, DD
    Consler, TG
    BIOCHEMISTRY, 1997, 36 (21) : 6283 - 6293
  • [7] TYROSINE DEPHOSPHORYLATION OF PP60(C-SRC) IS STIMULATED BY A SERINE/THREONINE PHOSPHATASE INHIBITOR
    CHACKALAPARAMPIL, I
    BAGRODIA, S
    SHALLOWAY, D
    ONCOGENE, 1994, 9 (07) : 1947 - 1955
  • [8] Characterization of the neuronal isoform of the protein tyrosine kinase pp60((c-src))
    Schoberl, C
    Ossendorf, E
    Barnekow, A
    EUROPEAN JOURNAL OF CELL BIOLOGY, 1997, 72 : 223 - 223
  • [9] Phosphorylation of growth factor receptor binding protein-2 by pp60(c-src) tyrosine kinase
    Jones, DA
    Benjamin, CW
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1997, 337 (02) : 143 - 148
  • [10] IDENTIFICATION OF EFFICIENT PENTAPEPTIDE SUBSTRATES FOR THE TYROSINE KINASE PP60(C-SRC)
    NAIR, SA
    KIM, MH
    WARREN, SD
    CHOI, S
    ZHOU, SY
    CANTLEY, LC
    HANGAUER, DG
    JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (21) : 4276 - 4283